Vilsboll T, Krarup T, Madsbad S, Holst JJ (2003) Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects
Always consult your OB-GYN or a qualified healthcare professional before introducing any new supplements to your diet while pregnant or breastfeeding
It is important to note that the glucose-raising effect of glucagon receptor activation is largely counterbalanced by the GLP-1 and GIP components
Wegovy producing 14.9% average weight loss in its Phase 3 trial was, at the time, the most effective obesity medication ever approved
Diabetes 2023;72(Supplement 1):51OR
These broader metabolic benefits are part of the reason researchers consider tripleagonist therapies multitarget obesity and metabolicdisease treatments rather than simple appetite suppressants. How Medically Supervised Programs May Use Retatrutide in the Future If ongoing trials continue to show strong benefits with acceptable safety, and if retatrutide eventually receives FDA approval, it is likely to become one more option in the toolbox for medically supervised weightloss programs rather than a standalone miracle drug. A careful, supervised approach would typically include: Comprehensive evaluation before prescribing Detailed medical history, including prior responses to GLP1 or dualagonist medications
